Eric F Fisher

Title: Eric F Fisher: Innovator in Tumor Necrosis Factor Research

Introduction

Eric F Fisher is a notable inventor based in Boulder, CO (US). He has made significant contributions to the field of biotechnology, particularly in the area of tumor necrosis factor research. With a total of 4 patents to his name, Fisher's work has implications for therapeutic advancements in cancer treatment.

Latest Patents

Fisher's latest patents include groundbreaking innovations such as nucleic acids encoding truncated soluble tumor necrosis factor. These patents disclose novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Additionally, he has developed truncated soluble tumor necrosis factor type-I and type-II receptors, which also involve processes for obtaining these proteins through recombinant genetic engineering techniques.

Career Highlights

Eric F Fisher is currently associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to focus on developing innovative solutions that address critical health challenges. Fisher's research has the potential to enhance the understanding and treatment of various diseases related to tumor necrosis factor.

Collaborations

Some of Fisher's notable coworkers include Carl Edwards, III and Gary Kieft. Their collaborative efforts contribute to the advancement of research in the field of biotechnology and cancer treatment.

Conclusion

Eric F Fisher's contributions to tumor necrosis factor research exemplify the impact of innovation in biotechnology. His patents and work at Amgen Inc. highlight the importance of scientific research in developing new therapeutic strategies.